BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24841354)

  • 1. Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy.
    Imai K; Beppu T; Yamao T; Okabe H; Hayashi H; Nitta H; Hashimoto D; Mima K; Nakagawa S; Sakamoto K; Chikamoto A; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Nov; 21(12):3817-26. PubMed ID: 24841354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is liver resection for hepatocellular carcinoma in cirrhotic patients with high preoperative serum alanine aminotransferase level unadvisable?
    Lai CY; Wu CC; Wang J; Yu CC; Cheng SB; Yeh DC; Peng FK
    Hepatogastroenterology; 2014 Oct; 61(135):2068-76. PubMed ID: 25713912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma.
    Uemura M; Sasaki Y; Yamada T; Gotoh K; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
    Ann Surg Oncol; 2014 May; 21(5):1719-25. PubMed ID: 24464342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.
    Kaibori M; Ishizaki M; Matsui K; Kwon AH
    J Surg Oncol; 2010 Oct; 102(5):462-8. PubMed ID: 20872949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
    Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
    Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy.
    Kaibori M; Ishizaki M; Matsui K; Kwon AH
    Am J Surg; 2012 Sep; 204(3):300-7. PubMed ID: 22591698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum hyaluronic acid level as a prognostic factor in patients undergoing hepatic resection for hepatocellular carcinoma.
    Mima K; Beppu T; Ishiko T; Chikamoto A; Nakagawa S; Hayashi H; Watanabe M; Sakamaki K; Baba H
    Br J Surg; 2014 Feb; 101(3):269-76. PubMed ID: 24446084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma.
    Itoh S; Shirabe K; Matsumoto Y; Yoshiya S; Muto J; Harimoto N; Yamashita Y; Ikegami T; Yoshizumi T; Nishie A; Maehara Y
    Ann Surg Oncol; 2014 Sep; 21(9):3063-8. PubMed ID: 24719020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.
    Zhou YM; Zhang XF; Li B; Sui CJ; Yang JM
    Ann Surg Oncol; 2014 Jul; 21(7):2406-12. PubMed ID: 24577811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum hyaluronic acid level as a good predictor of posthepatectomy complications.
    Nanashima A; Yamaguchi H; Tanaka K; Shibasaki S; Tsuji T; Ide N; Hidaka S; Sawai T; Nakagoe T; Nagayasu T
    Surg Today; 2004; 34(11):913-9. PubMed ID: 15526125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver.
    Faber W; Sharafi S; Stockmann M; Denecke T; Sinn B; Puhl G; Bahra M; Malinowski MB; Neuhaus P; Seehofer D
    Surgery; 2013 Apr; 153(4):510-7. PubMed ID: 23122930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
    Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
    J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; ViganĂ² L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients.
    Mizuguchi T; Kawamoto M; Meguro M; Son S; Nakamura Y; Harada K; Shibata T; Ota S; Hirata K
    Hepatogastroenterology; 2012; 59(114):551-7. PubMed ID: 22353523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.
    Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; lida T; Suzuki F; Furukawa K; Haruki K; Misawa T; Yanaga K
    Hepatogastroenterology; 2013 Oct; 60(127):1746-8. PubMed ID: 24634946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
    Zhang ZY; Zhou ZQ; Zhou GW
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.